Un estudio (en ingls) publicado el 24 de noviembre del 2025 en JAMA Internal Medicine sigui a 308 personas que toman tirzepatida durante 36 semanas
An open-label introductory period of the first 36 weeks, during which all subjects were treated with tirzepatide, followed by a 52-week double-blind treatment period, during which subjects were randomly assigned to receive either tirzepatide or placebo
This does not mean avoid fibre
Stage 1 includes individuals with higher risk of developing dysglycaemia (defined based on validated country-specific risk scores than those with stage 0 or normal -cell function, whose high insulin resistance would be compensated by increased insulin production and glucose remains near normal despite gradual minimal decline in -cell function or mass
As a result, patients often experience reduced cravings, improved portion control, and steadier progress over time
This is not to dismiss the heart rate effect, but rather to contextualize it within the broader cardiovascular picture